Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets

Maria Sofia Basile(University of Catania), Michele Reibaldi(Department of Medical Sciences), Vincenza Bonfiglio(University of Catania), Emanuela Mazzon(Centro Neurolesi Bonino Pulejo), Matteo Fallico(University of Catania), Antonio Longo(University of Catania), Ferdinando Nicoletti(University of Catania), Teresio Avitabile(University of Catania), Andrea Russo(University of Catania), Paolo Fagone(University of Catania)
Frontiers in Oncology
November 5, 2019
10.3389/fonc.2019.01145
Cited by 50

Related Papers

Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
|Aging|2011|707
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495